Pancreatic cells 'remember' cancer-linked epigenetic marks without mutations, study shows
Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between ...
EurekAlert!1d
Pancreatic cells ‘remember’ epigenetic precancerous marks without genetic sequence mutations
Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic “marks” in a transition state between ...
Managed Healthcare Executive1d
Trial Supports Bizengri as a Promising Treatment for NRG1 Fusion-Positive Cancers, Including Advanced Lung Cancer
A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...
Science Daily2d
In pancreatic cancer, a race against time
Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to ...
Cancer Therapy Advisor2d
Cabometyx Approved for Advanced Neuroendocrine Tumors
The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.
Attralus Presents New Data on Its Pan-Amyloid Diagnostic Candidates at the 2025 American College of Cardiology (ACC) Annual Scientific Session
PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis ...
Longevity Medical Institutetm Integrates Oncoseek® To Launch One Of Mexico's Most Advanced Cancer Screening Programs
A significant study detailing OncoSeek®'s efficacy was published in eClinicalMedicine, a clinical journal of The Lancet, titled A panel o ...